Polymorphisms in genes involved in the estrogen pathway and mammographic density

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Dumas, Isabelle ^a,b   Diorio, Caroline ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

17BETA HYDROXYSTEROID DEHYDROGENASE 1; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1B1; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG; CYP1B1 PROTEIN, HUMAN; CYTOCHROME P450; ESTRADIOL 17BETA DEHYDROGENASE; ESTROGEN; HSD17B1 PROTEIN, HUMAN; UNSPECIFIC MONOOXYGENASE;

ADULT; ARTICLE; BODY MASS; BREAST TUMOR; CAUCASIAN; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENOTYPE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENARCHE; PARITY; PREMENOPAUSE; SINGLE NUCLEOTIDE POLYMORPHISM; AGE; BREAST DISEASE; CANADA; CHI SQUARE DISTRIBUTION; ETHNOLOGY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; PHENOTYPE; PREGNANCY; RADIOGRAPHY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGE FACTORS; ARYL HYDROCARBON HYDROXYLASES; BODY MASS INDEX; BREAST DISEASES; BREAST NEOPLASMS; CATECHOL O-METHYLTRANSFERASE; CHI-SQUARE DISTRIBUTION; CYTOCHROME P-450 ENZYME SYSTEM; ESTRADIOL DEHYDROGENASES; ESTROGENS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINEAR MODELS; LINKAGE DISEQUILIBRIUM; MAMMOGRAPHY; MIDDLE AGED; PARITY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PREMENOPAUSE; QUEBEC; RISK ASSESSMENT; RISK FACTORS;

EID: 78549283832     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-636     Document Type: Article

References (56)

1. Russo J, Russo IH. Genotoxicity of steroidal estrogens. Trends Endocrinol Metab 2004, 15(5):211-4. 10.1016/j.tem.2004.05.007, 15223050.
2. Kulendran M, Salhab M, Mokbel K. Oestrogen-synthesising enzymes and breast cancer. Anticancer Res 2009, 29(4):1095-109.
3. Oduwole OO, Li Y, Isomaa VV, Mantyniemi A, Pulkka AE, Soini Y, et al. 17beta-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer. Cancer Res 2004, 64(20):7604-9. 10.1158/0008-5472.CAN-04-0446, 15492288.
4. Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 1996, 36:203-32. 10.1146/annurev.pa.36.040196.001223, 8725388.
5. Mitrunen K, Hirvonen A. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 2003, 544(1):9-41. 10.1016/S1383-5742(03)00016-4, 12888106.
6. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, Sutter TR. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci USA 1996, 93(18):9776-81. 10.1073/pnas.93.18.9776, 38505, 8790407.
7. Zhu BT, Conney AH. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis?. Cancer Res 1998, 58(11):2269-77.
8. Sanchez R, Nguyen D, Rocha W, White JH, Mader S. Diversity in the mechanisms of gene regulation by estrogen receptors. Bioessays 2002, 24(3):244-54. 10.1002/bies.10066, 11891761.
9. Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, et al. Polymorphic catechol-O-methyltransferase gene and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001, 10(6):635-40.
10. Okobia MN, Bunker CH, Garte SJ, Zmuda JM, Ezeome ER, Anyanwu SN, et al. Cytochrome P450 1B1 Val432Leu polymorphism and breast cancer risk in Nigerian women: a case control study. Infect Agent Cancer 2009, 4(Suppl 1):S12. 10.1186/1750-9378-4-S1-S12, 2638457, 19208203.
11. Shin A, Kang D, Nishio H, Lee MJ, Park SK, Kim SU, et al. Estrogen receptor alpha gene polymorphisms and breast cancer risk. Breast Cancer Res Treat 2003, 80(1):127-31. 10.1023/A:1024439202528, 12889606.
12. Thompson PA, Shields PG, Freudenheim JL, Stone A, Vena JE, Marshall JR, et al. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res 1998, 58(10):2107-10.
13. Wedren S, Rudqvist TR, Granath F, Weiderpass E, Ingelman-Sundberg M, Persson I, et al. Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer risk. Carcinogenesis 2003, 24(4):681-7. 10.1093/carcin/bgg022, 12727796.
14. Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, et al. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res 1997, 57(24):5493-7.
15. Kocabas NA, Sardas S, Cholerton S, Daly AK, Karakaya AE. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population. Arch Toxicol 2002, 76(11):643-9. 10.1007/s00204-002-0387-x, 12415427.
16. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15(6):1159-69. 10.1158/1055-9965.EPI-06-0034, 16775176.
17. Heine JJ, Malhotra P. Mammographic tissue, breast cancer risk, serial image analysis, and digital mammography. Part 1. Tissue and related risk factors. Acad Radiol 2002, 9(3):298-316. 10.1016/S1076-6332(03)80373-2, 11887946.
18. Boyd NF, Jensen HM, Cooke G, Han HL, Lockwood GA, Miller AB. Mammographic densities and the prevalence and incidence of histological types of benign breast disease. Reference Pathologists of the Canadian National Breast Screening Study. Eur J Cancer Prev 2000, 9(1):15-24. 10.1097/00008469-200002000-00003, 10777006.
19. Conner P, Soderqvist G, Skoog L, Graser T, Walter F, Tani E, et al. Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology. Breast Cancer Res Treat 2003, 78(2):159-65. 10.1023/A:1022987618445, 12725416.
20. Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR, et al. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002, 347(12):886-94. 10.1056/NEJMoa013390, 12239257.
21. Li J, Eriksson L, Humphreys K, Czene K, Liu J, Tamimi RM, et al. Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer. Breast Cancer Res 12(2):R19. 10.1186/bcr2488, 2879563, 20214802.
22. Warren R, Skinner J, Sala E, Denton E, Dowsett M, Folkerd E, et al. Associations among mammographic density, circulating sex hormones, and polymorphisms in sex hormone metabolism genes in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2006, 15(8):1502-8. 10.1158/1055-9965.EPI-05-0828, 16896040.
23. Lord SJ, Mack WJ, Van Den Berg D, Pike MC, Ingles SA, Haiman CA, et al. Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study. Breast Cancer Res 2005, 7(3):R336-44. 10.1186/bcr999, 1143576, 15987428.
24. de Moura ramos EH. Association between estrogen receptor gene polymorphisms and breast density in postmenopausal women. CLIMACTERIC 2009, (12):490-501. 10.3109/13697130902952585, 19905901.
25. Stone J, Gurrin LC, Byrnes GB, Schroen CJ, Treloar SA, Padilla EJ, et al. Mammographic density and candidate gene variants: a twins and sisters study. Cancer Epidemiol Biomarkers Prev 2007, 16(7):1479-84. 10.1158/1055-9965.EPI-07-0107, 17627014.
26. van Duijnhoven FJ, Bezemer ID, Peeters PH, Roest M, Uitterlinden AG, Grobbee DE, et al. Polymorphisms in the estrogen receptor alpha gene and mammographic density. Cancer Epidemiol Biomarkers Prev 2005, 14(11 Pt 1):2655-60. 10.1158/1055-9965.EPI-05-0398, 16284392.
27. van Duijnhoven FJ, Peeters PH, Warren RM, Bingham SA, Uitterlinden AG, van Noord PA, et al. Influence of estrogen receptor alpha and progesterone receptor polymorphisms on the effects of hormone therapy on mammographic density. Cancer Epidemiol Biomarkers Prev 2006, 15(3):462-7. 10.1158/1055-9965.EPI-05-0754, 16537702.
28. Haiman CA, Hankinson SE, De Vivo I, Guillemette C, Ishibe N, Hunter DJ, et al. Polymorphisms in steroid hormone pathway genes and mammographic density. Breast Cancer Res Treat 2003, 77(1):27-36. 10.1023/A:1021112121782, 12602902.
29. Haiman CA, Bernstein L, Berg D, Ingles SA, Salane M, Ursin G. Genetic determinants of mammographic density. Breast Cancer Res 2002, 4(3):R5. 10.1186/bcr434, 111030, 12052257.
30. Takata Y, Maskarinec G, Le Marchand L. Breast density and polymorphisms in genes coding for CYP1A2 and COMT: the Multiethnic Cohort. BMC Cancer 2007, 7:30. 10.1186/1471-2407-7-30, 1800856, 17295924.
31. Hong CC, Thompson HJ, Jiang C, Hammond GL, Tritchler D, Yaffe M, et al. Val158Met Polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 2003, 12(9):838-47.
32. Maskarinec G, Lurie G, Williams AE, Le Marchand L. An investigation of mammographic density and gene variants in healthy women. Int J Cancer 2004, 112(4):683-8. 10.1002/ijc.20448, 15382051.
33. Crandall CJ, Sehl ME, Crawford SL, Gold EB, Habel LA, Butler LM, et al. Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women. Breast Cancer Res 2009, 11(4):R51. 10.1186/bcr2340, 2750112, 19630952.
34. Vachon CM, Sellers TA, Pankratz VS. Mammographic density of the breast. N Engl J Med 2003, 348(2):174-5. author reply-5, 10.1056/NEJM200301093480215, 12519932.
35. Diorio C, Pollak M, Byrne C, Masse B, Hebert-Croteau N, Yaffe M, et al. Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev 2005, 14(5):1065-73. 10.1158/1055-9965.EPI-04-0706, 15894654.
36. London SJ, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Speizer FE. Prospective study of relative weight, height, and risk of breast cancer. JAMA 1989, 262(20):2853-8. 10.1001/jama.262.20.2853, 2810620.
37. Caan BJ, Slattery ML, Potter J, Quesenberry CP, Coates AO, Schaffer DM. Comparison of the Block and the Willett self-administered semiquantitative food frequency questionnaires with an interviewer-administered dietary history. Am J Epidemiol 1998, 148(12):1137-47.
38. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995, 87(9):670-5. 10.1093/jnci/87.9.670, 7752271.
39. Diorio C, Brisson J, Berube S, Pollak M. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels. Cancer Epidemiol Biomarkers Prev 2008, 17(4):880-8. 10.1158/1055-9965.EPI-07-2500, 18398029.
40. Cai Q, Shu XO, Jin F, Dai Q, Wen W, Cheng JR, et al. Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 2003, 12(9):853-9.
41. Feigelson HS, Cox DG, Cann HM, Wacholder S, Kaaks R, Henderson BE, et al. Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies. Cancer Res 2006, 66(4):2468-75. 10.1158/0008-5472.CAN-05-3574, 16489054.
42. Stram DO, Leigh Pearce C, Bretsky P, Freedman M, Hirschhorn JN, Altshuler D, et al. Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals. Hum Hered 2003, 55(4):179-90. 10.1159/000073202, 14566096.
43. Tsuchiya Y, Nakajima M, Kyo S, Kanaya T, Inoue M, Yokoi T. Human CYP1B1 is regulated by estradiol via estrogen receptor. Cancer Res 2004, 64(9):3119-25. 10.1158/0008-5472.CAN-04-0166, 15126349.
44. Jiang H, Xie T, Ramsden DB, Ho SL. Human catechol-O-methyltransferase down-regulation by estradiol. Neuropharmacology 2003, 45(7):1011-8. 10.1016/S0028-3908(03)00286-7, 14573393.
45. Xie T, Ho SL, Ramsden D. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol 1999, 56(1):31-8.
46. Lonning PE, Helle H, Duong NK, Ekse D, Aas T, Geisler J. Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status. J Steroid Biochem Mol Biol 2009, 117(1-3):31-41. 10.1016/j.jsbmb.2009.06.005, 19591931.
47. Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia. Metabolism 2009, 58(1):1-7. 10.1016/j.metabol.2008.07.016, 19059524.
48. Bernstein L, Pike MC, Ross RK, Judd HL, Brown JB, Henderson BE. Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst 1985, 74(4):741-5.
49. Shimada T, Watanabe J, Kawajiri K, Sutter TR, Guengerich FP, Gillam EM, et al. Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis 1999, 20(8):1607-13. 10.1093/carcin/20.8.1607, 10426814.
50. Andrysik Z, Vondracek J, Machala M, Krcmar P, Svihalkova-Sindlerova L, Kranz A, et al. The aryl hydrocarbon receptor-dependent deregulation of cell cycle control induced by polycyclic aromatic hydrocarbons in rat liver epithelial cells. Mutat Res 2007, 615(1-2):87-97.
51. Uzunov P, Vlasov V. Epithelial proliferations in organ cultures of mouse lung treated with urethane and 3,4-benzopyrene. Eksp Med Morfol 1976, 15(2):103-7.
52. Apter D, Reinila M, Vihko R. Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood. Int J Cancer 1989, 44(5):783-7. 10.1002/ijc.2910440506, 2511157.
53. Dawling S, Roodi N, Mernaugh RL, Wang X, Parl FF. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res 2001, 61(18):6716-22.
54. Syvanen AC, Tilgmann C, Rinne J, Ulmanen I. Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and parkinsonian patients in Finland. Pharmacogenetics 1997, 7(1):65-71. 10.1097/00008571-199702000-00009, 9110364.
55. Khoury MJ. Fundamentals of genetic epidemiology. 1993, 19. NY: Oxfard University press, Monographs in epidemiology and biostatistics.
56. Rothman KJ, Greenland S. Modern epidemiology. 1998, Philadelphia, PA: Lippincott-Raven.